Mesalamine
FDA Approved
Contents
Description
Mesalamine is an aminosalicylate anti-inflammatory agent that acts locally in the colon and rectum. It is used for the treatment of inflammatory bowel disease and has shown benefit in managing radiation-induced proctitis. The rectal formulation delivers the medication directly to the affected tissue, reducing inflammation and promoting mucosal healing.
Indications & Therapeutic Use
Ulcerative colitis, radiation proctitis, proctosigmoiditis
Linked Diseases:
Radiation proctitis
K62.7
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Mesalamine — GNH India
30 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
LIALDA
1.2gtabletUSA
Mesacol
800mgtabletIndia
Mesalamine
.375 g/1capsule, extended releaseUSA
Rowasa
4GM/60 MLenemaUSA
sfRowasa Sulfite-Free Formulation
4 g/60mLsuspensionUSA
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Mesalamine
| Generic Name | Mesalamine |
| Brands | 1 brand available |
| Active Ingredient | Mesalamine |
| Drug Class | Ulcerative colitis |
| Manufacturer | Allergan |
| Dosage Forms | Rectal suppository 1000mg, rectal suspension 4g/60mL, oral tablet 400mg, 800mg, 1200mg |
| Medical Code | A07EC02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes